Enhancing left ventricular relaxation through neuromodulation
Neuromodulation is used to enhance left ventricular relaxation. An exemplary neuromodulation system includes a therapy element positionable in proximity to at least one nerve fiber, and a stimulator configured to energize the therapy element to delivery therapy to the at least one nerve fiber such that left ventricular relaxation and left ventricular contractility are contemporaneously enhanced.
1. A method of treating a patient having a left ventricular contractility (LVC) and a left ventricular relaxation (LVR), comprising:
administering an inotropic agent to the patient to enhance LVC and delivering neuromodulation therapy to the patient to contemporaneously enhance LVR, such that the ratio of the enhancement of LVC to the enhancement of LVR is within a predetermined range, wherein the enhancement of LVR is determined by determining the increase in a value selected from dP/dt min in diastole, arterial blood pressure (ABP) in diastole, tau in diastole, mitral valve deceleration time or mitral valve velocity time interval from prior to initiation of neuromodulation to after initiation of neuromodulation.
2. The method of claim 1 , wherein the neuromodulation therapy includes:
using a therapy element positioned in an intravascular location to neuromodulate at least one extravascular nerve fiber to increase LVR.
3. The method of claim 2 , wherein the intravascular location is selected from the group of blood vessels consisting of the superior vena cava, left brachiocephalic vein and right brachiocephalic vein.
4. The method of claim 2 , wherein the intravascular location is selected from the group of blood vessels consisting of the superior vena cava, left brachiocephalic vein, lower internal jugular vein, right brachiocephalic vein, azygos vein or azygos arch.
5. The method of claim 1 , wherein the neuromodulation therapy is delivered to enhance LVR such that the ratio of the percentage increase of LVC to the percentage increase of LVR is within a predetermined range.
6. The method of claim 5 , wherein the predetermined range is 0.5-1.5.
7. The method of claim 5 , wherein the predetermined range is 0.8-1.2.
8. The method of claim 5 , wherein the predetermined range is approximately 1.0.
9. The method of claim 1 wherein the method includes automatically adjusting at least one neuromodulation parameter such that the ratio of the enhancement of LVC to the enhancement of LVR is within the predetermined range.
10. The method of claim 9 , wherein the therapy elements are electrodes and the neuromodulation parameter adjusted by the system is at least one of electrical currents, voltages, and pulse widths, pulse frequency, charge density, effective electrode surface area, effective electrode spacing, and electrode combinations energized.
11. A method of treating a patient having a left ventricular contractility (LVC) and a left ventricular relaxation (LVR), comprising:
administering an inotropic agent to the patient to enhance LVC and delivering neuromodulation therapy to the patient to contemporaneously enhance LVR, such that the ratio of the enhancement of LVC to the enhancement of LVR is within a predetermined range, wherein the enhancement of LVC is determined by determining the increase in the value selected from dP/dt max in systole, ABP in systole, from prior to initiation of neuromodulation to after initiation of neuromodulation.
12. The method of claim 11 , wherein the neuromodulation therapy includes:
using a therapy element positioned in an intravascular location to neuromodulate at least one extravascular nerve fiber to increase LVR.
13. The method of claim 12 , wherein the intravascular location is selected from the group of blood vessels consisting of the superior vena cava, left brachiocephalic vein and right brachiocephalic vein.
14. The method of claim 12 , wherein the intravascular location is selected from the group of blood vessels consisting of the superior vena cava, left brachiocephalic vein, lower internal jugular vein, right brachiocephalic vein, azygos vein or azygos arch.
15. The method of claim 11 , wherein the neuromodulation therapy is delivered to enhance LVR such that the ratio of the percentage increase of LVC to the percentage increase of LVR is within a predetermined range.
16. The method of claim 15 , wherein the predetermined range is 0.5-1.5.
17. The method of claim 15 , wherein the predetermined range is 0.8-1.2.
18. The method of claim 15 , wherein the predetermined range is approximately 1.0.
19. The method of claim 11 wherein the method includes automatically adjusting at least one neuromodulation parameter such that the ratio of the enhancement of LVC to the enhancement of LVR is within the predetermined range.
20. The method of claim 11 , wherein the therapy elements are electrodes and the neuromodulation parameter adjusted by the system is at least one of electrical currents, voltages, and pulse widths, pulse frequency, charge density, effective electrode surface area, effective electrode spacing, and electrode combinations energized.